文献速递新生儿儿童感染

新生儿期高剂量庆大霉素暴露与学龄期听力关联的随访研究

Hearing in Schoolchildren After Neonatal Exposure to a High-Dose Gentamicin Regimen.
PubMed 文献 · Pediatrics · 2020-01-08

本研究纳入2004-2012年新生儿期接受高剂量庆大霉素(6 mg/kg)方案的儿童219例及健康对照33例,学龄期行纯音测听(含扩展高频)。结果显示庆大霉素暴露与听力阈值升高无关,校正出生体重后暴露组与对照组无差异。

要点

  • 新生儿期高剂量庆大霉素暴露与学龄期听力阈值升高无显著关联。
  • 校正出生体重后,暴露组与健康对照组听力阈值无差异。
  • 听力阈值升高与较低出生体重及生后中耳疾病相关。

核心结论

  • 新生儿期高剂量庆大霉素方案暴露与能完成测听的学龄儿童听力阈值升高无关。

研究设计与样本

  • 研究纳入2004-2012年新生儿期接受高剂量(6 mg/kg)庆大霉素方案的儿童,并邀请学龄期随访,同时设健康年龄匹配对照组。
  • 听力评估采用纯音测听,包括扩展高频(EHF)范围;结局为中频(0.5-4 kHz)和EHF(9-16 kHz)平均听阈。
  • 庆大霉素暴露指标为累积剂量和最高谷浓度血浆浓度;采用线性回归模型评估暴露及其他围产期和生后疾病对听阈的影响。
  • 听力学分析共纳入219例庆大霉素暴露儿童和33例健康对照儿童。

主要发现

  • 庆大霉素队列中39例(17%)出生体重<1500 g。
  • 中位累积剂量为30(四分位距24-42)mg/kg,中位谷浓度血浆浓度为1.0(四分位距0.7-1.2)mg/L。
  • 中频和EHF中位听阈分别为2.5(0至6.3)dB hearing level和-1.7(-5.0至5.0)dB hearing level,均在正常范围。
  • 校正分析中,听阈升高与较低出生体重和生后中耳疾病相关,而与庆大霉素暴露水平无关。
  • 校正出生体重后,庆大霉素暴露队列与健康对照的听阈无差异。

临床怎么用

  • 对于新生儿期接受高剂量庆大霉素方案的儿童,学龄期听力阈值未见与暴露水平相关的升高。
  • 临床关注学龄期听力时,应重视较低出生体重和生后中耳疾病等围产期及生后疾病的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the association between gentamicin exposure in the neonatal period and hearing in school age. METHODS: This study included children exposed to a high-dose (6 mg/kg) gentamicin regimen as neonates (2004-2012), invited for follow-up at school age, and a healthy age-matched control group. We assessed hearing with pure tone audiometry including the extended high-frequency (EHF) range. Outcomes were average hearing thresholds in the midfrequencies (0.5-4 kHz) and the EHFs (9-16 kHz). The measures of gentamicin exposure were cumulative dose and highest trough plasma concentration. We used linear regression models to assess the impact of gentamicin exposure, and other peri- and postnatal morbidities, on hearing thresholds. RESULTS: A total of 219 gentamicin-exposed and 33 healthy-control children were included in the audiological analysis. In the gentamicin cohort, 39 (17%) had a birth weight <1500 g. Median cumulative doses and trough plasma concentrations were 30 (interquartile range 24-42) mg/kg and 1.0 (interquartile range 0.7-1.2) mg/L, respectively. Median hearing thresholds for the midfrequencies and the EHFs were 2.5 (0 to 6.3) dB hearing level and -1.7 (-5.0 to 5.0) dB hearing level, both of which were within the normal range. In an adjusted analysis, increasing hearing thresholds were associated with lower birth weight and postnatal middle-ear disease but not level of gentamicin exposure. After adjusting for birth weight, there was no difference in hearing threshold between the gentamicin-exposed cohort and healthy controls. CONCLUSIONS: Exposure to a high-dose gentamicin regimen in the neonatal period was not associated with an increase in hearing thresholds in schoolchildren being able to complete audiometry.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Hemmingsen D, Mikalsen C, Hansen AR, et al. Hearing in Schoolchildren After Neonatal Exposure to a High-Dose Gentamicin Regimen. Pediatrics. 2020. PMID: 31915192. doi:10.1542/peds.2019-2373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。